The U.S. Food and Drug Administration is warning the public about criminals posing as FDA special agents and other law enforcement personnel as part of an international extortion scam. The criminals call the victims — who in most cases previously purchased drugs over the Internet or via “telepharmacies” — and identify themselves as FDA special agents or other law enforcement officials…
On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) — including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees — discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate)…
Go to Source… Continue reading
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced that the U.S…
Go to Source… Continue reading
Boston Scientific Corporation (NYSE: BSX) announced that the U.S. Food and Drug Administration (FDA) has approved its Express® LD Iliac Premounted Stent System for use in iliac arteries. The Express LD Iliac Stent is the first and only low-profile, premounted, balloon-expandable stent approved by the FDA for use in treating iliac artery disease. The Company said it plans to launch the product immediately in the United States…
Go to Source… Continue reading
Utah’s health department will use $6.3 million in federal dollars to build a “computer pipeline” that will allow doctors and hospitals to share patient information, The Salt Lake Tribune reports. The pipeline is paid for by the federal economic stimulus package, and the state will contract with the nonprofit Utah Health Information Network to build it. With the pipeline, “doctors could … retrieve data from another provider about a patient’s medical history, allergies or prescriptions. … Participating clinics would pay a yearly subscription fee. And no one would have access to a patient’s medical record unless the patient authorized it.”… Continue reading
SANUWAVE Health, Inc., (OTC BB: SNWV), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that a journal article titled Extracorporeal Shock Wave Therapy for Nonunion of the Tibia, was published in the March 2010 issue of the Journal of Orthopedic Trauma…
Go to Source… Continue reading
